AOL Web Search

  1. About 3,880,000 search results

    168.89-0.62 (-0.37%)

    at Thu, Jan 26, 2023, 4:00PM EST - U.S. markets open in 3 hours 19 minutes

    Pre Mkt 168.55 -0.34 (-0.20%)

    Nasdaq Real Time Price

    • Ask Price 0.00
    • Bid Price 0.00
    • P/E 25.10
    • 52 Wk. High 186.69
    • 52 Wk. Low 155.72
    • Mkt. Cap 441.56B
  1. Web results:
  2. FDA restricts J&J’s COVID-19 vaccine due to blood clot risk

    nypost.com/2022/05/05/fda-restricts-jjs-covid-19...

    FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on the risk of life-threatening blood clots within two weeks of...

  3. FDA limits J&J COVID-19 vaccine due to rare blood clot risk

    abcnews.go.com/Health/fda-limits-jj-covid-19...

    The U.S. Food and Drug Administration on Thursday announced it's now limiting the authorized use of the Johnson & Johnson vaccine after conducting an updated investigation into reports of rare blood clots.

    • FDA restricts J&J’s COVID-19 vaccine due to blood clot risk
      YouTube
    • FDA restricts J&J’s COVID-19 vaccine due to risk of blood clots
      Microsoft News
    • FDA restricts J&J's COVID-19 vaccine due to blood clot risk
      YouTube
    • FDA Restricts J&J’s COVID-19 Vaccine Due To Blood Clot Risk
      YouTube
  4. FDA Restricts J&J's COVID-19 Vaccine Due to Blood Clot Risk

    www.usnews.com/news/business/articles/2022-05-05/...

    FDA Restricts J&J's COVID-19 Vaccine Due to Blood Clot Risk FILE - Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in Denver on Saturday, March 6, 2021. On...

  5. FDA restricts Johnson & Johnson’s COVID-19 vaccine due to ...

    www.pbs.org/newshour/health/fda-restricts...

    FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

  6. FDA restricts Johnson & Johnson COVID-19 vaccine due to blood ...

    www.cbsnews.com/news/covid-vaccine-johnson-and...

    FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two weeks of...

  7. FDA advises pausing J&J Covid vaccine after blood-clotting ...

    www.cnbc.com/2021/04/13/us-regulators-reportedly...

    The FDA is asking states to temporarily halt using J&J’s Covid-19 vaccine after six people in the U.S. developed a rare blood-clotting disorder. The FDA said the recommendation is “out of...

  8. FDA Limits Use of J&J COVID Vaccine Over Blood Clot Risk - WebMD

    www.webmd.com/vaccines/covid-19-vaccine/news/...

    Last December, the CDC’s Advisory Committee on Immunization Practices. said the Pfizer and Moderna vaccines were preferred over J&J because J&J carried the rare risk of blood clots and...

  9. J & J COVID vaccine use is restricted by FDA due to blood ...

    www.usatoday.com/story/news/health/2022/05/05/...

    FDA vaccine chief Dr. Peter Marks said the agency made the decision after re-examining the data on the risks of life-threatening blood clots, concluding that they are limited to J&J's vaccine.

  10. Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine

    www.fda.gov/news-events/press-announcements/...

    As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a...

  11. The Link Between J&J’s COVID Vaccine and Blood Clots: What ...

    www.yalemedicine.org/news/coronavirus-vaccine...

    But blood clots became a concern starting in April 2021, when the government put a pause on the J&J shot after six women who received it developed rare blood clots—and one died. All of these cases were reported to the Vaccine Adverse Events Reporting System (VAERS), a national early reporting warning system to detect safety problems with U.S ...